Evidence Hub

P123 Management challenges in rheumatoid arthritis-associated interstitial lung disease: insights from a real-world case series

K. Garg, S. Nafea, A. Nandagudi

Rheumatology Advances in Practice, 2025

Abstract

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a significant extra-articular manifestation that affects approximately 10% of RA patients and contributes to increased morbidity and mortality. The most common radiological patterns are usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), with variable clinical progression. Diagnosis is often delayed due to subtle respiratory symptoms and lack of routine screening. Treatment remains challenging, with limited data guiding immunosuppressive or antifibrotic use. This case series explores the clinical features, diagnostic timelines, pulmonary function profiles, and therapeutic strategies in RA-ILD, highlighting real-world challenges and variability in patient management across multidisciplinary settings.

We conducted a retrospective case-series of patients with confirmed rheumatoid arthritis-associated interstitial lung disease (RA-ILD) managed at our centre. Clinical data including demographics, ILD subtype, RA serostatus, smoking history, referral patterns, pulmonary function tests (PFTs), and treatment regimens were extracted from patient records. Ten patients were identified (5 males, 5 females), with a median age of 75.1 years (range 56–86). ILD subtype was confirmed by high-resolution CT in all cases: 4 patients had usual interstitial pneumonia (UIP), 4 had nonspecific interstitial pneumonia (NSIP), and 2 had early unclassified ILD. The median time lag from RA diagnosis to…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free